The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Candesartan Krka 8 mg tablets

8 milligram(s) Tablet

KRKA, d.d., Novo mestoPA1347/026/002

Main Information

Trade NameCandesartan Krka 8 mg tablets
Active SubstancesCandesartan cilexetil
Strength8 milligram(s)
Dosage FormTablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/026/002

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA06 candesartan

Status

Authorised/WithdrawnAuthorised
Licence Issued09/03/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan 8mg Tablets
Interchangeable List CodeIC0009-009-002
Interchangeable List DocumentPDF of Interchangeable List
« Back